The effect air and noise pollution can have on the development of neurodegenerative diseases is not fully understood, but results from a large study published in The Lancet suggest living close to heavy-traffic roadways could increase the risk of developing dementia — but not other neurological diseases, such as multiple sclerosis (MS)…
risk factors
Lack of physical activity and a poor diet may be the most common risk factors for poor health and survival in patients with multiple sclerosis (MS), according to a study. The research, “Individual And Co-Occurring SNAP Risk Factors,” was published in the International Journal of MS Care. The development…
A new study confirmed the involvement of three genetic variants, or mutations, of the interleukin-23A (IL-23A) gene, and one variant of its receptor IL-23R, in the risk of developing multiple sclerosis (MS) and other related inflammatory nervous disorders, together known as inflammatory demyelinating diseases (IDD). Details of this study, “Characterization of…
The risk of developing multiple sclerosis (MS) later in life may be higher for babies born with low levels of vitamin D, according to a new study in the journal Neurology. The study, “Neonatal Vitamin D Status And Risk Of Multiple Sclerosis – A Population-Based Case-Control Study,” was…
Multiple sclerosis (MS), especially in premenopausal women, does not seem to be associated with breast cancer, as suggested in previous studies, researchers reported. And, they argue, the higher incidences of this cancer in postmenopausal women with MS may be due more to surveillance bias than true risk. These findings were detailed in the study, “…
My neurologist calls Lemtrada “HSCT lite.” She says that not only is the drug able to reduce exacerbations and limit the overall progression of multiple sclerosis, it’s actually reversed some symptoms in some of her patients. I guess I’m going to find out if she’s right about…
I made a trip to the dentist today. What does that have to do with multiple sclerosis, you ask? Stay with me. We’ll get there. But first, let me tell you about a weekend conference that my local chapter of the National Multiple Sclerosis Society held recently. One of…
The jury is still out on the role, if any, that heavy metals play in multiple sclerosis. Many theories have been floating around for years regarding the possible connection between MS and dental amalgams, pesticides, additives to food, lead paint in older homes … and the list goes on. The National…
In a large prospective study with validated measures of physical activity, researchers found no evidence that exercise reduced a woman’s risk of developing multiple sclerosis (MS). Although physical activity is known to have numerous health benefits, it seems unlikely to protect a person against the likelihood of developing MS, the study concludes. The study, published…
Exposure to heavy metals and being female are associated with a higher incidence of multiple sclerosis (MS), according to a study conducted by Maria Cristina Monti and colleagues from two Italian universities. The study, “Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia,” was…
In a large nationwide study in Finland, researchers found evidence supporting the link between vitamin D deficiency and an increased risk for multiple sclerosis (MS) in women. The results were given in an oral presentation, “Serum levels of 25-hydroxyvitamin D and risk of multiple sclerosis among women in the Finnish Maternity Cohort,”…
Early detection is very important for any disease diagnosis. With Multiple Sclerosis, it gives you the opportunity to start a treatment plan early that may help with slowing the progression of the disease. Symptoms of MS vary widely from person to person and can closely mimic other disease symptoms. Lesions don’t always…
Gut microbiota (the ecological community of microorganisms that live in the gut) may be an important environmental risk factor for multiple sclerosis (MS). This suggests that strategies to correct the imbalance in the normal intestinal flora, also known as microbial dysbiosis may help treat or event prevent MS.
Childhood Obesity Linked to Higher Risk of Multiple Sclerosis, Possibly by Altering Vitamin D Levels
Obese children and young adults appear to be at a considerably higher risk of developing multiple sclerosis (MS), according to researchers at the McGill University in Canada and collaborators at the University of Bristol in the U.K., who found a causal relationship between the two. Their study, “…
High blood pressure may be linked to greater overall disability in people with multiple sclerosis (MS), although the rate at which disability progresses might be slower than in patients without hypertension, a retrospective study concludes. The research, involving a large number of MS patients, helps to clarify a rather confusing range of views on how…
4 New ‘Risk Genes’ for Multiple Sclerosis, All Controlling Other Genes, Identified in German Study
In the largest genetic study ever performed in a single country, scientists in Germany discovered four new risk genes for multiple sclerosis (MS). The genes, altered in MS patients, are involved in the control of how other genes are activated through mechanisms known as epigenetics. The discovery advances understanding of how…
Processed foods have been added to the list of “no-no” items that we are not supposed to eat if you, like me, are unfortunate enough to have MS. We were already warned against gluten, salt and various other ingredients in our diet; now it’s processed foods and additives. This is…
Autologous haematopoietic stem cell transplantation (aHSCT) has been used to stop autoimmune processes in multiple sclerosis (MS), although the treatment is not effective for every person. Now, an improved version of the technique is showing astonishingly good results, with patients free of both the need for treatment and the risk of relapses for…
Gut Microbiota in Young MS Patients Is Higher in Pro-Inflammatory Bacteria Than Usual, Study Finds
Children and adolescents with multiple sclerosis (MS) differ from others in the composition of their gut flora, with higher levels of inflammation-causing bacteria and lower levels of anti-inflammatory bacteria, according to a study from the University of British Columbia, Canada. The findings, supporting previous hypotheses that the composition of the gut microbial community could influence the development…
Mitoxantrone, a multiple sclerosis (MS) drug that is already associated with a higher risk for leukemia and heart damage, may also raise a person’s risk of colorectal cancer, researchers at the University of Würzburg, in Germany, reported. If confirmed in larger studies, the findings indicate that colonoscopies should be conducted on MS patients after…
A systematic review of existing medical literature on multiple sclerosis (MS) could shed light on MS causes and predictors for disease progression, and on lifestyle changes — ranging from vitamin D intake to weight loss — that might reduce a person’s risk. The report, “Factors associated with onset, relapses…
Smoking Appears Linked to Brain Abnormalities in People with MS-related Disease, Study Suggests
A team of researchers suggested that cigarette smoking is associated with adverse effects to white matter in the brain, and reported that smoking may underlie the clinical course of clinically isolated syndrome, an early and potentially predictive symptom of a progression to multiple sclerosis (MS). The study, “Influence of cigarette smoking on white matter in patients with…
The National Multiple Sclerosis Society is funding a new survey to understand how people living with multiple sclerosis (MS) weigh risks against benefits when choosing MS therapies. The survey was developed by Dr. Robert Fox, a neurologist, working with colleagues at the Cleveland Clinic and the MS patient…
Rosacea is an inflammatory skin condition affecting mostly fair-skinned individuals. A study from the University of Copenhagen, Denmark, recently showed that the condition in women is also associated with multiple sclerosis (MS). Recent genome wide association studies (GWAS) have pinpointed genetic risk factors of the disease that also increase…
Certain therapies used to treat multiple sclerosis (MS) have been associated with opportunistic infections of the central nervous system, including progressive multifocal leukoencephalopathy (PML), a rare but often fatal brain disorder caused by the John Cunningham (JC) virus. The question of whether the risk for opportunistic infections to MS patients outweighs…
A large-scale online survey, funded by the National Multiple Sclerosis Society and developed by researchers, is investigating how multiple sclerosis (MS) patients perceive and evaluate the risks and benefits of available therapies. Investigators encourage MS patients to participate in the survey, titled “Multiple Sclerosis Risk Tolerance,” which can be…
Children whose mothers were vitamin D deficient during the early stages of pregnancy are at an elevated risk for developing multiple sclerosis (MS) in adulthood, according to a study published in the journal JAMA Neurology, titled “Vitamin D Status During Pregnancy and Risk of Multiple…
A new research study published online in the Journal of Neurology, Neurosurgery & Psychiatry suggests that drinking six cups of coffee a day could lower the risk of developing multiple sclerosis (MS). The researchers said the neuroprotective and anti-inflammatory properties of caffeine in coffee may explain why drinking a…
Researchers at the University of Northampton’s Radon and Natural Radioactivity Research Group (RNRRG) developed a methodology to study whether radon gas, an invisible and radioactive gas known to cause lung cancer, might be a contributing factor in multiple sclerosis. They concluded that the link between the two was weak and not statistically significant.
For MS Patients, New Guidelines for Controlling Rare Brain Infection Risk Under Tysabri Treatment
The European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC), responsible for assessing and monitoring safety issues for human medicines, completed a review on the risk for progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients treated with the medicine Tysabri (natalizumab). The issued guidelines have the objective of minimizing patients’ risk.
Recommended Posts
- ‘Molecular atlas’ uses military blood samples to spot disease years early
- Living between the lines: MS, motherhood, and the invisible load
- Trial of CAR T-cell therapy for progressive MS now recruiting in US
- The ‘pre-flight safety checklist’ applies to both MS patients and caregivers
- Vitamin D supplementation shows mixed effects in new MS meta-analysis